BSX insider files Form 144 to sell 50,000 common shares
Rhea-AI Filing Summary
Boston Scientific (BSX) insider Joseph M. Fitzgerald filed a Form 144 indicating an intended sale of 50,000 shares of common stock, with an aggregate market value $4,973,335. The sales are planned for approximately 11/03/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.
The shares were acquired via stock option exercise on 11/03/2025 for cash. As context, 1,482,442,039 shares were outstanding. Over the past three months, Fitzgerald sold 50,000 shares on 10/01/2025 for $4,923,325 and 50,000 shares on 09/02/2025 for $5,271,415.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice for planned secondary sales.
Form 144 notifies potential sales by an affiliate under Rule 144. Here, Joseph M. Fitzgerald lists a planned sale of 50,000 shares of Boston Scientific common stock, with an $4,973,335 aggregate market value and an approximate sale date of 11/03/2025. The broker is Morgan Stanley Smith Barney LLC Executive Financial Services and the venue is the NYSE.
The filing states the shares were acquired via stock option exercise on 11/03/2025 for cash. The excerpt also lists prior three-month sales: 50,000 shares on 10/01/2025 for $4,923,325 and 50,000 on 09/02/2025 for $5,271,415. Shares outstanding were 1,482,442,039, a baseline figure disclosed by the issuer.
Actual sales and timing depend on market conditions and Rule 144 parameters. Subsequent filings may provide execution details if sales occur.